Author: Kathy Whitney
Heart Institute testing world’s tiniest pacemaker
Sep. 18, 2014—Vanderbilt Heart and Vascular Institute is participating in a global clinical trial to test the safety and efficacy of the world’s smallest pacemaker.
Meet Rivka Ihejirika, a third-year medical student from Los Angeles
Sep. 17, 2014—Rivka Ihejirika is a third-year medical student from Los Angeles. She is the recipient of the Cornelius Vanderbilt Scholarship and the James Edward Holloran Scholarship, established by the Class of 1980.
Nashville Heart Walk hits Vanderbilt campus on Oct. 4
Sep. 11, 2014—The 2014 Greater Nashville Heart Walk will take place on Vanderbilt’s campus on Saturday, Oct. 4.
Stallworth debuts hemodialysis service for rehab patients
Sep. 4, 2014—Vanderbilt Stallworth Rehabilitation Hospital (VSRH) is now offering hemodialysis for its patients, eliminating the need to transport them off site for treatment.
Team effort key to ease patient’s rare heart disorder
Aug. 21, 2014—Vanderbilt employee Drew Casey, 27, was at home when he began to experience shortness of breath. Thinking it might be a panic attack, his wife, Katie, called 911, and an ambulance took Casey to the Emergency Department, where he progressed very suddenly to circulatory failure and shock.
Study tracks new end-stage renal disease therapy
Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.
AHA grant creates coalition to prevent heart disease, stroke
Jul. 10, 2014—Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
VU study shows common diabetes drug can slow chronic kidney disease progression
Jun. 26, 2014—Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes.
Photo: Vanderbilt Heart Town Hall
Jun. 19, 2014—Keith Churchwell, M.D., executive director and chief medical officer of the Vanderbilt Heart and Vascular Institute, spoke at last week’s Town Hall, a quarterly gathering of Vanderbilt Heart faculty and staff. Churchwell announced that Vanderbilt Heart – Shelbyville has moved into new office space and that a new outreach clinic has opened in Collinwood, Tennessee....
New center dedicated to kidney disease
May. 29, 2014—Kidney disease is the eighth most common cause of death in the United States and affects more than 20 million people, yet many people don’t know they have kidney disease because it often develops very slowly and with minimal symptoms. For this reason, kidney disease is often referred to as a silent killer.
Classmates unite to create medical scholarships
May. 22, 2014—Whether it’s former classmates or perfect strangers coming together to support a great cause, there is no denying that there is strength in numbers.
VHVI educates airport screeners on heart devices
May. 8, 2014—Thanks to advances in technology, heart patients with ventricular assist devices (VADs) are able to travel with greater frequency.